AGM

Extraordinary General Meeting (EGM) on 30 March 2021
Please find here all documents including the convocation and the agenda for the EGM scheduled on 30 March 2021.
 

On the registration date ("Record Time") for the EGM, Kiadis Pharma N.V. had 42,894,008 shares issued, each representing one vote. 

Kiadis Pharma will hold its Annual General Meeting ("AGM") of shareholders at Thursday 10:00 CEST on 25 June 2020.

Kiadis Pharma will hold its Annual General Meeting (“AGM”) of shareholders at 10:00 (CEST) on Monday 24 June 2019 at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

Kiadis Pharma N.V. has convened an extraordinary general meeting of shareholders (“EGM”) to obtain shareholder approval pursuant to section 2:107a of the Dutch Civil Code for the proposed acquisition of CytoSen Therapeutics, Inc. that was announced earlier today. The EGM is to be held on Wednesday, May 29, 2019 at 10:00am CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands. On the registration date (registratiedatum) for the EGM, Kiadis Pharma N.V. had 24,345,076 shares issued, each representing one vote.

Kiadis Pharma N.V. has convened an extraordinary general meeting of shareholders (“EGM”) to be held on Friday 29 March 2019 at 10:00 CET at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

Kiadis Pharma held its Annual General Meeting (AGM) of Shareholders on Monday 4 June 2018 at 10:00 CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.